retatrutide status fda approval: status, clinical trial results, and when it could be available Retatrutide for Weight Loss: TRIUMPH-1

is now 7.2 mg per week as of March 2026, following FDA review of the STEP UP trial

None of these substitute for medication, but they have legitimate places in a broader metabolic health plan

Indeed, the cardioprotective effects of GLP-1RAs exceeded those of dietary weight loss, indicating direct and weight-loss-independent cardiac effects of liraglutide and semaglutide in HFpEF (31, 32)

The synergistic effect of the imbalanced agonism is working in such a way that it maximizes the benefits of each incretin hormone while significantly reducing the side effects

Changing your environment by limiting your exposure to food-related media or by getting rid of items that you associate with emotional eating could make it less likely that you start thinking about eating in the first place

Be prepared with comorbidity documentation anyway because it strengthens your prior authorization